Zhonglian He
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Breast Cancer Treatment Studies 5
- Cancer, Lipids, and Metabolism 3
-
- Pancreatic and Hepatic Oncology Research 2
-
- Advanced Radiotherapy Techniques 3
-
- Liver Disease Diagnosis and Treatment 2
-
- RNA modifications and cancer 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
Zhonglian He
16 papers receiving 315 citations
Peers
Comparison fields: 5 of 63
- Hepatology 56
- Pulmonary and Respiratory Medicine 178
- Cancer Research 76
- Complementary and alternative medicine 39
- Oncology 75
Countries citing papers authored by Zhonglian He
This map shows the geographic impact of Zhonglian He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonglian He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonglian He more than expected).
Fields of papers citing papers by Zhonglian He
This network shows the impact of papers produced by Zhonglian He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonglian He. The network helps show where Zhonglian He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhonglian He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2019 | 19 | |
| 8 | Comparison of six irradiation techniques for delivering hypofractionated whole-breast radiotherapy with a simultaneous integrated boost after breast-conserving surgery | 2018 | 0 |
| 9 | 2018 | 1 | |
| 10 | 2018 | 63 | |
| 11 | 2017 | 33 | |
| 12 | 2015 | 10 | |
| 13 | 2014 | 10 | |
| 14 | 2013 | 9 | |
| 15 | 2012 | 21 | |
| 16 | 2009 | 61 | |
| 17 | 2009 | 83 |
About Zhonglian He
Zhonglian He is a scholar working on Cancer Research, Otorhinolaryngology and Hepatology, having authored 17 papers that have together received 320 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer, Lipids, and Metabolism (3 papers), Advanced Radiotherapy Techniques (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), RNA modifications and cancer (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Hepatology (56 citations), Pulmonary and Respiratory Medicine (178 citations) and Cancer Research (76 citations). Zhonglian He has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Huan‐Xin Lin, Xueping Wang, Qiao‐Qiao Li, Minjie Mao, Denis E. O’Donnell, H Magnussen, Justin Travers, François Maltais, A. Hamilton and Steven Kesten. Their work appears in journals such as Nucleic Acids Research, Annals of Oncology and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.